Homoeopathic Antimiasmatic Medicines In The Treatment Of Generalised Anxiety Disorder

The Role Of Homoeopathic antimiasmatic Medicines In The Treatment Of Generalised Anxiety Disorder

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050941

Enrollment

Registered

2023-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Homoeopathic medicines: Homoeopathic medicines are selected based on individualization of the patient. Based on the susceptibility of the patient the dose is selected. Medicine is admin

Eligibility

Inclusion criteria

Inclusion criteria: Both male and female patients are included Age group 18 to 40 years

Exclusion criteria

Exclusion criteria: Patients with active treatment for any other chronic diseases like hypertension,diseases of thyroid,cardiovascular diseases

Design outcomes

Secondary

Measure	Time frame
It is expected that the proposed study will be useful in reducing the symptoms of generalised anxiety disorderTimepoint: At baseline and after six months	—

Primary

Measure	Time frame
Diagnosis based on clinical presentation such as problems sleeping,difficulties with concentration ,angry outbursts, Hamilton anxiety scaleTimepoint: At baseline and after 6 months	—

Countries

India

Contacts

Public ContactDr KS LALITHAA

Vinayaka missions Homoeopathic Medical college and Hospital

drlalithaagogul@gmail.com9940245577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026